NOVOLOG
These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG.NOVOLOG (insulin aspart) injection, for subcutaneous or intravenous useInitial U.S. Approval: 2000
3a1e73a2-3009-40d0-876c-b4cb2be56fc5
HUMAN PRESCRIPTION DRUG LABEL
Feb 28, 2023
Novo Nordisk
DUNS: 622920320
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
insulin aspart
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
water injection
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
insulin aspart
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
insulin aspart
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
insulin aspart
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
insulin aspart
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
insulin aspart
Product Details
FDA regulatory identification and product classification information